Cortisol Secretion, Sensitivity, and Activity Are Associated With Hypertension in Postmenopausal Eucortisolemic Women

Iacopo Chiodini, Agostino Gaudio, Cristina Eller-Vainicher, Valentina Morelli, Carmen Aresta, Volha V. Zhukouskaya, Daniela Merlotti, Emanuela Orsi, Anna Maria Barbieri, Silvia Fustinoni, Elisa Polledri, Luigi Gennari, Alberto Falchetti, Vincenzo Carnevale, Luca Persani, Alfredo Scillitani

Research output: Contribution to journalArticle

Abstract

CONTEXT: Previous data suggest a possible association between type 2 diabetes (T2D) and fragility fractures (FX) with the degree of glucocorticoid suppressibility (GCS) and peripheral activation or sensitivity even in persons without hypercortisolemia. OBJECTIVE: To investigate whether the degree of GCS, GC sensitivity, and peripheral activation in persons without overt or mild hypercortisolism are associated with hypertension and with the number of the possible consequences of cortisol excess among patients with T2D, fragility FX, and hypertension. DESIGN: Case-control study. SETTING: Outpatient clinic. PATIENTS: A total of 216 postmenopausal women without hypercortisolemia (age, 50 to 80 years; 108 with hypertension); 68 and 99 patients had fragility FX and T2D, respectively. MAIN OUTCOME MEASURES: We assessed 24-hour urinary free cortisol (UFF), cortisone (UFE), their ratio (R-UFF/UFE), (F-1mgDST), and the GC receptor N363S single-nucleotide polymorphism (N363S-SNP). RESULTS: Hypertension was associated with F-1 mgDST [odds ratio (OR), 3.3; 95% CI, 1.5 to 7.5; P = 0.004) and R-UFF/UFE (OR, 101.7; 95% CI, 2.6 to 4004.1; P = 0.014), regardless of age, body mass index, and presence of the N363S single nucleotide polymorphism and of T2D. The progressive increase in the number of possible consequences of cortisol excess was significantly associated with F-1mgDST levels (R2 = 0.125; P = 0.04), R-UFF/UFE (R2 = 0.46; P = 0.02), and the prevalence of N363S heterozygous variant (T = 0.46; P = 0.015), after adjustment for age. CONCLUSIONS: In postmenopausal women without hypercortisolemia, hypertension is associated with GCS and GC peripheral activation. The number of possible consequences of cortisol excess (among patients with hypertension, T2D, and fragility FX) is associated with GCS, GC peripheral activation, and the prevalence of the N363S heterozygous variant.

Original languageEnglish
Pages (from-to)4441-4448
Number of pages8
JournalThe Journal of clinical endocrinology and metabolism
Volume104
Issue number10
DOIs
Publication statusPublished - Oct 1 2019

Fingerprint

Medical problems
Cortisone
Hydrocortisone
Type 2 Diabetes Mellitus
Glucocorticoids
Hypertension
Chemical activation
Polymorphism
Nucleotides
Single Nucleotide Polymorphism
Odds Ratio
Cushing Syndrome
Ambulatory Care Facilities
Association reactions
Case-Control Studies
Body Mass Index

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Cortisol Secretion, Sensitivity, and Activity Are Associated With Hypertension in Postmenopausal Eucortisolemic Women. / Chiodini, Iacopo; Gaudio, Agostino; Eller-Vainicher, Cristina; Morelli, Valentina; Aresta, Carmen; Zhukouskaya, Volha V.; Merlotti, Daniela; Orsi, Emanuela; Barbieri, Anna Maria; Fustinoni, Silvia; Polledri, Elisa; Gennari, Luigi; Falchetti, Alberto; Carnevale, Vincenzo; Persani, Luca; Scillitani, Alfredo.

In: The Journal of clinical endocrinology and metabolism, Vol. 104, No. 10, 01.10.2019, p. 4441-4448.

Research output: Contribution to journalArticle

@article{b65e73ccba084d7d85b4636e67df7831,
title = "Cortisol Secretion, Sensitivity, and Activity Are Associated With Hypertension in Postmenopausal Eucortisolemic Women",
abstract = "CONTEXT: Previous data suggest a possible association between type 2 diabetes (T2D) and fragility fractures (FX) with the degree of glucocorticoid suppressibility (GCS) and peripheral activation or sensitivity even in persons without hypercortisolemia. OBJECTIVE: To investigate whether the degree of GCS, GC sensitivity, and peripheral activation in persons without overt or mild hypercortisolism are associated with hypertension and with the number of the possible consequences of cortisol excess among patients with T2D, fragility FX, and hypertension. DESIGN: Case-control study. SETTING: Outpatient clinic. PATIENTS: A total of 216 postmenopausal women without hypercortisolemia (age, 50 to 80 years; 108 with hypertension); 68 and 99 patients had fragility FX and T2D, respectively. MAIN OUTCOME MEASURES: We assessed 24-hour urinary free cortisol (UFF), cortisone (UFE), their ratio (R-UFF/UFE), (F-1mgDST), and the GC receptor N363S single-nucleotide polymorphism (N363S-SNP). RESULTS: Hypertension was associated with F-1 mgDST [odds ratio (OR), 3.3; 95{\%} CI, 1.5 to 7.5; P = 0.004) and R-UFF/UFE (OR, 101.7; 95{\%} CI, 2.6 to 4004.1; P = 0.014), regardless of age, body mass index, and presence of the N363S single nucleotide polymorphism and of T2D. The progressive increase in the number of possible consequences of cortisol excess was significantly associated with F-1mgDST levels (R2 = 0.125; P = 0.04), R-UFF/UFE (R2 = 0.46; P = 0.02), and the prevalence of N363S heterozygous variant (T = 0.46; P = 0.015), after adjustment for age. CONCLUSIONS: In postmenopausal women without hypercortisolemia, hypertension is associated with GCS and GC peripheral activation. The number of possible consequences of cortisol excess (among patients with hypertension, T2D, and fragility FX) is associated with GCS, GC peripheral activation, and the prevalence of the N363S heterozygous variant.",
author = "Iacopo Chiodini and Agostino Gaudio and Cristina Eller-Vainicher and Valentina Morelli and Carmen Aresta and Zhukouskaya, {Volha V.} and Daniela Merlotti and Emanuela Orsi and Barbieri, {Anna Maria} and Silvia Fustinoni and Elisa Polledri and Luigi Gennari and Alberto Falchetti and Vincenzo Carnevale and Luca Persani and Alfredo Scillitani",
year = "2019",
month = "10",
day = "1",
doi = "10.1210/jc.2019-00037",
language = "English",
volume = "104",
pages = "4441--4448",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - Cortisol Secretion, Sensitivity, and Activity Are Associated With Hypertension in Postmenopausal Eucortisolemic Women

AU - Chiodini, Iacopo

AU - Gaudio, Agostino

AU - Eller-Vainicher, Cristina

AU - Morelli, Valentina

AU - Aresta, Carmen

AU - Zhukouskaya, Volha V.

AU - Merlotti, Daniela

AU - Orsi, Emanuela

AU - Barbieri, Anna Maria

AU - Fustinoni, Silvia

AU - Polledri, Elisa

AU - Gennari, Luigi

AU - Falchetti, Alberto

AU - Carnevale, Vincenzo

AU - Persani, Luca

AU - Scillitani, Alfredo

PY - 2019/10/1

Y1 - 2019/10/1

N2 - CONTEXT: Previous data suggest a possible association between type 2 diabetes (T2D) and fragility fractures (FX) with the degree of glucocorticoid suppressibility (GCS) and peripheral activation or sensitivity even in persons without hypercortisolemia. OBJECTIVE: To investigate whether the degree of GCS, GC sensitivity, and peripheral activation in persons without overt or mild hypercortisolism are associated with hypertension and with the number of the possible consequences of cortisol excess among patients with T2D, fragility FX, and hypertension. DESIGN: Case-control study. SETTING: Outpatient clinic. PATIENTS: A total of 216 postmenopausal women without hypercortisolemia (age, 50 to 80 years; 108 with hypertension); 68 and 99 patients had fragility FX and T2D, respectively. MAIN OUTCOME MEASURES: We assessed 24-hour urinary free cortisol (UFF), cortisone (UFE), their ratio (R-UFF/UFE), (F-1mgDST), and the GC receptor N363S single-nucleotide polymorphism (N363S-SNP). RESULTS: Hypertension was associated with F-1 mgDST [odds ratio (OR), 3.3; 95% CI, 1.5 to 7.5; P = 0.004) and R-UFF/UFE (OR, 101.7; 95% CI, 2.6 to 4004.1; P = 0.014), regardless of age, body mass index, and presence of the N363S single nucleotide polymorphism and of T2D. The progressive increase in the number of possible consequences of cortisol excess was significantly associated with F-1mgDST levels (R2 = 0.125; P = 0.04), R-UFF/UFE (R2 = 0.46; P = 0.02), and the prevalence of N363S heterozygous variant (T = 0.46; P = 0.015), after adjustment for age. CONCLUSIONS: In postmenopausal women without hypercortisolemia, hypertension is associated with GCS and GC peripheral activation. The number of possible consequences of cortisol excess (among patients with hypertension, T2D, and fragility FX) is associated with GCS, GC peripheral activation, and the prevalence of the N363S heterozygous variant.

AB - CONTEXT: Previous data suggest a possible association between type 2 diabetes (T2D) and fragility fractures (FX) with the degree of glucocorticoid suppressibility (GCS) and peripheral activation or sensitivity even in persons without hypercortisolemia. OBJECTIVE: To investigate whether the degree of GCS, GC sensitivity, and peripheral activation in persons without overt or mild hypercortisolism are associated with hypertension and with the number of the possible consequences of cortisol excess among patients with T2D, fragility FX, and hypertension. DESIGN: Case-control study. SETTING: Outpatient clinic. PATIENTS: A total of 216 postmenopausal women without hypercortisolemia (age, 50 to 80 years; 108 with hypertension); 68 and 99 patients had fragility FX and T2D, respectively. MAIN OUTCOME MEASURES: We assessed 24-hour urinary free cortisol (UFF), cortisone (UFE), their ratio (R-UFF/UFE), (F-1mgDST), and the GC receptor N363S single-nucleotide polymorphism (N363S-SNP). RESULTS: Hypertension was associated with F-1 mgDST [odds ratio (OR), 3.3; 95% CI, 1.5 to 7.5; P = 0.004) and R-UFF/UFE (OR, 101.7; 95% CI, 2.6 to 4004.1; P = 0.014), regardless of age, body mass index, and presence of the N363S single nucleotide polymorphism and of T2D. The progressive increase in the number of possible consequences of cortisol excess was significantly associated with F-1mgDST levels (R2 = 0.125; P = 0.04), R-UFF/UFE (R2 = 0.46; P = 0.02), and the prevalence of N363S heterozygous variant (T = 0.46; P = 0.015), after adjustment for age. CONCLUSIONS: In postmenopausal women without hypercortisolemia, hypertension is associated with GCS and GC peripheral activation. The number of possible consequences of cortisol excess (among patients with hypertension, T2D, and fragility FX) is associated with GCS, GC peripheral activation, and the prevalence of the N363S heterozygous variant.

UR - http://www.scopus.com/inward/record.url?scp=85072057804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072057804&partnerID=8YFLogxK

U2 - 10.1210/jc.2019-00037

DO - 10.1210/jc.2019-00037

M3 - Article

C2 - 31112276

AN - SCOPUS:85072057804

VL - 104

SP - 4441

EP - 4448

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 10

ER -